Wall Street Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Wall Street Associates’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-37,456	Closed	-$1.47M	–	315
2014 Q1	$1.47M	Hold	37,456	–	–	0.12%	193
2013 Q4	$897K	Sell	37,456 -2,420	-6%	-$55.2K	0.07%	220
2013 Q3	$1.11M	Buy	+39,876	New	+$1.1M	0.1%	201

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wall Street Associates's AGIO Position: Q2 2014 in Review

Wall Street Associates sold out of Agios Pharmaceuticals (AGIO) in Q2 2014, closing a stake of 37,456 shares — an estimated $1.47M sold.

Wall Street Associates first reported a position in AGIO in Q3 2013 and held it in 3 quarters. The position peaked at $1.47M in Q1 2014. 99 funds tracked by Wall St. Rank hold AGIO as of Q2 2014.

Wall Street Associates reported no remaining Agios Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Wall Street Associates sold 37,456 Agios Pharmaceuticals shares in Q2 2014, an estimated $1.47M.
Wall Street Associates first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 3 quarters.
Wall Street Associates's Agios Pharmaceuticals position peaked at $1.47M in Q1 2014.
99 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2014.

Based on Wall Street Associates's 13F filing for Q2 2014, filed 14 Aug 2014.